Amicus Therapeutics, Inc. (LON:0HF9)

Amicus Therapeutics Revenue

Amicus Therapeutics had revenue of $154.69M USD in the quarter ending June 30, 2025, with 22.12% growth. This brings the company's revenue in the last twelve months to $571.16M, up 25.35% year-over-year. In the year 2024, Amicus Therapeutics had annual revenue of $528.30M with 32.29% growth.

• Revenue (ttm): $571.16M
• Revenue Growth: +25.35%
• P/S Ratio: 4.31
• Revenue / Employee: $1.14M
• Employees: 499
• Market Cap: 1.80B GBP

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	528.30M	128.94M	32.29%
Dec 31, 2023	399.36M	70.12M	21.30%
Dec 31, 2022	329.23M	23.72M	7.76%
Dec 31, 2021	305.51M	44.63M	17.11%
Dec 31, 2020	260.89M	78.65M	43.16%